Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PET Pharmaceuticals is a UK-based biotechnology company focused on developing phytopharmaceutical medicines for companion animals. The company aims to bridge the gap between traditional veterinary medicine and the increasing demand for natural, scientifically-backed remedies for pets. Their research focuses on leveraging plant-based compounds to treat common animal health issues such as osteoarthritis, anxiety, and chronic pain. PET Pharmaceuticals works to validate these natural formulations through clinical research to provide veterinarians and pet owners with regulated, effective alternatives to conventional synthetic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PET.